ICPMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Author
US Environmental Protection Agency (EPA)
U.S. Environmental Protection Agency’s (EPA) mission is to protect human health and the environment. EPA works to ensure that: Americans have clean air, land and water; National efforts to reduce environmental risks are based on the best available scientific information; Federal laws protecting human health and the environment are administered and enforced fairly, effectively and as Congress intended; Environmental stewardship is integral to U.S. policies concerning natural resources, human health, economic growth, energy, transportation, agriculture, industry, and international trade, and these factors are similarly considered in establishing environmental policy; All parts of society--communities, individuals, businesses, and state, local and tribal governments--have access to accurate information sufficient to effectively participate in managing human health and environmental risks; Contaminated lands and toxic sites are cleaned up by potentially responsible parties and revitalized; and Chemicals in the marketplace are reviewed for safety.
Tags
Article
Health
Environment
Food
Science and research
Logo of LinkedIn

EPA, FDA and USDA Issues Updates to the Joint Regulatory Plan for Biotechnology

Mo, 8.7.2024
| Original article from: US Environmental Protection Agency (EPA)
EPA, FDA and USDA have developed a plan to update, streamline and clarify their regulations and oversight mechanisms for products of biotechnology.
- **Photo:** US Environmental Protection Agency: US Environmental Protection Agency press release
  • Photo: US Environmental Protection Agency: US Environmental Protection Agency press release

WASHINGTON – Today, May 8, 2024, in response to President Biden’s Executive Order 14081, “Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy,” the U.S. Environmental Protection Agency, the U.S. Food and Drug Administration and the U.S. Department of Agriculture have developed a plan to update, streamline and clarify their regulations and oversight mechanisms for products of biotechnology.

The plan helps meet the President’s goals of ensuring public confidence in the biotechnology regulatory system and improving its transparency, predictability, coordination and efficiency. Through engagement with developers and stakeholders, as well as horizon scanning for novel biotechnology products, the agencies worked collaboratively to develop a cohesive plan. The plan incorporates processes and timelines to implement regulatory reform, such as identifying guidance and regulations to update, streamline, or clarify, and identifying the potential need for new guidance or regulations. The plan supports a whole-of-government approach to the regulation of biotechnology products.

The agencies have identified five major areas of biotechnology product regulation where these actions will focus:

  1. Modified plants
  2. Modified animals
  3. Modified microorganisms
  4. Human drugs, biologics and medical devices
  5. Cross-cutting issues

EPA, the FDA and USDA intend to implement the following joint efforts:

  • Clarify and streamline regulatory oversight for genetically engineered plants, animals and microorganisms;
  • Update and expand their information sharing through an MOU to improve and broaden communication and coordination of oversight of modified microbes; and
  • Undertake a pilot project focused on modified microbes to explore and consider the feasibility and costs of developing a web-based tool that informs developers about which agency may regulate a given product category.

The federal government established the Coordinated Framework for the Regulation of Biotechnology in 1986 and most recently updated it in 2017. It describes the comprehensive federal regulatory policy for ensuring the safety of biotechnology products, including how EPA, the FDA and USDA share responsibility for regulating many of the products of biotechnology in the United States. The Executive Order directs the three agencies to improve how they implement the Coordinated Framework.

In response to the Executive Order, the three regulatory agencies, in consultation with the Office of Science and Technology Policy, issued a Request for Information to the public to solicit information on regulatory ambiguities, gaps, uncertainties or inefficiencies in the Coordinated Framework. The agencies received 88 distinct public comments, including a sign-on letter from over 6,000 members from biotechnology developers, producers, manufacturers, non-governmental organizations and academia. The agencies will continue to engage with all interested stakeholders as they implement the plan.

Visit the Unified Website for Biotechnology Regulation for additional information on modernizing the regulatory system for biotechnology products and Executive Order 14081.

US Environmental Protection Agency (EPA)
 

Related content

Quantifying the Similarity of Two Coffee Bean Products by GC/MS and EDXRF

Applications
| 2024 | Shimadzu
Instrumentation
X-ray, GC/MSD, GC/MS/MS, GC/QQQ, SPME
Manufacturer
Shimadzu
Industries
Food & Agriculture

Multifaceted Evaluation of IgG Glycan Profiles Considering the Components in Glycosyltransferase Reactions

Applications
| 2024 | Shimadzu
Instrumentation
ICP/MS, LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

WATER NEEDS IN PHARMA QUALITY CONTROL

Brochures and specifications
| 2019 | ELGA LabWater
Instrumentation
Laboratory instruments
Manufacturer
ELGA LabWater
Industries
Pharma & Biopharma

Elemental Analysis in Yeast Cells and Selenium Enriched Yeast Cells by ICP-MS with Automated Micro-Flow Sample Introduction

Posters
| 2024 | Agilent Technologies (ASMS)
Instrumentation
ICP/MS, ICP/MS/MS
Manufacturer
Elemental Scientific, Agilent Technologies
Industries
Clinical Research

Screening Analysis of 24 Elemental Impurity Elements in Drugs Using ICPMS-2040/2050

Applications
| 2024 | Shimadzu
Instrumentation
ICP/MS
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
 

Related articles


Article | Scientific article

Sugar metabolism is surprisingly conventional in cancer

Study has implications for targeting metabolism in cancer treatment.
Washington University in St. Louis
more

Article | Video

RESEARCHERS SERVE UP AN IMPROVED MODEL OF INDOOR POLLUTION PRODUCED BY COOKING

New approach could inform better public health guidelines.
Johns Hopkins University
more

Article | Video

Why urea may have been the gateway to life

Urea reacts extremely quickly under the conditions that existed when our planet was newly formed. This new insight furthers our understanding of how life on Earth might have begun.
ETH Zürich
more

Article | Video

Scientists at IOCB Prague are developing a new generation of DNA tests for a wide range of applications

A research group led by Dr. Edward Curtis has developed two new types of catalytic DNA molecules (deoxyribozymes) that can reveal the presence of target molecules through fluorescence or color.
Ústav organické chemie a biochemie AV ČR
more
 

Related content

Quantifying the Similarity of Two Coffee Bean Products by GC/MS and EDXRF

Applications
| 2024 | Shimadzu
Instrumentation
X-ray, GC/MSD, GC/MS/MS, GC/QQQ, SPME
Manufacturer
Shimadzu
Industries
Food & Agriculture

Multifaceted Evaluation of IgG Glycan Profiles Considering the Components in Glycosyltransferase Reactions

Applications
| 2024 | Shimadzu
Instrumentation
ICP/MS, LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

WATER NEEDS IN PHARMA QUALITY CONTROL

Brochures and specifications
| 2019 | ELGA LabWater
Instrumentation
Laboratory instruments
Manufacturer
ELGA LabWater
Industries
Pharma & Biopharma

Elemental Analysis in Yeast Cells and Selenium Enriched Yeast Cells by ICP-MS with Automated Micro-Flow Sample Introduction

Posters
| 2024 | Agilent Technologies (ASMS)
Instrumentation
ICP/MS, ICP/MS/MS
Manufacturer
Elemental Scientific, Agilent Technologies
Industries
Clinical Research

Screening Analysis of 24 Elemental Impurity Elements in Drugs Using ICPMS-2040/2050

Applications
| 2024 | Shimadzu
Instrumentation
ICP/MS
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
 

Related articles


Article | Scientific article

Sugar metabolism is surprisingly conventional in cancer

Study has implications for targeting metabolism in cancer treatment.
Washington University in St. Louis
more

Article | Video

RESEARCHERS SERVE UP AN IMPROVED MODEL OF INDOOR POLLUTION PRODUCED BY COOKING

New approach could inform better public health guidelines.
Johns Hopkins University
more

Article | Video

Why urea may have been the gateway to life

Urea reacts extremely quickly under the conditions that existed when our planet was newly formed. This new insight furthers our understanding of how life on Earth might have begun.
ETH Zürich
more

Article | Video

Scientists at IOCB Prague are developing a new generation of DNA tests for a wide range of applications

A research group led by Dr. Edward Curtis has developed two new types of catalytic DNA molecules (deoxyribozymes) that can reveal the presence of target molecules through fluorescence or color.
Ústav organické chemie a biochemie AV ČR
more
 

Related content

Quantifying the Similarity of Two Coffee Bean Products by GC/MS and EDXRF

Applications
| 2024 | Shimadzu
Instrumentation
X-ray, GC/MSD, GC/MS/MS, GC/QQQ, SPME
Manufacturer
Shimadzu
Industries
Food & Agriculture

Multifaceted Evaluation of IgG Glycan Profiles Considering the Components in Glycosyltransferase Reactions

Applications
| 2024 | Shimadzu
Instrumentation
ICP/MS, LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

WATER NEEDS IN PHARMA QUALITY CONTROL

Brochures and specifications
| 2019 | ELGA LabWater
Instrumentation
Laboratory instruments
Manufacturer
ELGA LabWater
Industries
Pharma & Biopharma

Elemental Analysis in Yeast Cells and Selenium Enriched Yeast Cells by ICP-MS with Automated Micro-Flow Sample Introduction

Posters
| 2024 | Agilent Technologies (ASMS)
Instrumentation
ICP/MS, ICP/MS/MS
Manufacturer
Elemental Scientific, Agilent Technologies
Industries
Clinical Research

Screening Analysis of 24 Elemental Impurity Elements in Drugs Using ICPMS-2040/2050

Applications
| 2024 | Shimadzu
Instrumentation
ICP/MS
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
 

Related articles


Article | Scientific article

Sugar metabolism is surprisingly conventional in cancer

Study has implications for targeting metabolism in cancer treatment.
Washington University in St. Louis
more

Article | Video

RESEARCHERS SERVE UP AN IMPROVED MODEL OF INDOOR POLLUTION PRODUCED BY COOKING

New approach could inform better public health guidelines.
Johns Hopkins University
more

Article | Video

Why urea may have been the gateway to life

Urea reacts extremely quickly under the conditions that existed when our planet was newly formed. This new insight furthers our understanding of how life on Earth might have begun.
ETH Zürich
more

Article | Video

Scientists at IOCB Prague are developing a new generation of DNA tests for a wide range of applications

A research group led by Dr. Edward Curtis has developed two new types of catalytic DNA molecules (deoxyribozymes) that can reveal the presence of target molecules through fluorescence or color.
Ústav organické chemie a biochemie AV ČR
more
 

Related content

Quantifying the Similarity of Two Coffee Bean Products by GC/MS and EDXRF

Applications
| 2024 | Shimadzu
Instrumentation
X-ray, GC/MSD, GC/MS/MS, GC/QQQ, SPME
Manufacturer
Shimadzu
Industries
Food & Agriculture

Multifaceted Evaluation of IgG Glycan Profiles Considering the Components in Glycosyltransferase Reactions

Applications
| 2024 | Shimadzu
Instrumentation
ICP/MS, LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

WATER NEEDS IN PHARMA QUALITY CONTROL

Brochures and specifications
| 2019 | ELGA LabWater
Instrumentation
Laboratory instruments
Manufacturer
ELGA LabWater
Industries
Pharma & Biopharma

Elemental Analysis in Yeast Cells and Selenium Enriched Yeast Cells by ICP-MS with Automated Micro-Flow Sample Introduction

Posters
| 2024 | Agilent Technologies (ASMS)
Instrumentation
ICP/MS, ICP/MS/MS
Manufacturer
Elemental Scientific, Agilent Technologies
Industries
Clinical Research

Screening Analysis of 24 Elemental Impurity Elements in Drugs Using ICPMS-2040/2050

Applications
| 2024 | Shimadzu
Instrumentation
ICP/MS
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
 

Related articles


Article | Scientific article

Sugar metabolism is surprisingly conventional in cancer

Study has implications for targeting metabolism in cancer treatment.
Washington University in St. Louis
more

Article | Video

RESEARCHERS SERVE UP AN IMPROVED MODEL OF INDOOR POLLUTION PRODUCED BY COOKING

New approach could inform better public health guidelines.
Johns Hopkins University
more

Article | Video

Why urea may have been the gateway to life

Urea reacts extremely quickly under the conditions that existed when our planet was newly formed. This new insight furthers our understanding of how life on Earth might have begun.
ETH Zürich
more

Article | Video

Scientists at IOCB Prague are developing a new generation of DNA tests for a wide range of applications

A research group led by Dr. Edward Curtis has developed two new types of catalytic DNA molecules (deoxyribozymes) that can reveal the presence of target molecules through fluorescence or color.
Ústav organické chemie a biochemie AV ČR
more
Other projects
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike